The consistent tumour growth-suppressive effects of dn forms of ERα in ERα-positive epithelial tumours [25,26 and this study], encourage experimental attempts towards the introduction of dnERα in tissue-specific targeting in the setting of the skin cancer treatment. This evidence concerns the gene ESR1 and skin neoplasm.